Novel hybrid molecules &
therapeutic formulas
We design. CROs discover. You benefit.
Start a PartnershipWhat We Do
Concept-to-Candidate Design – we create therapeutic formulas and novel hybrid molecules across pharmaceuticals, biologics, nutraceuticals, dietary supplements, and traditional/herbal medicine.
How We Work
- We design the molecular concept & therapeutic formula
- Contracted CROs execute full drug-discovery workflow (in-silico → in-vitro → in-vivo)
- CROs formulate into oral, injectable, topical, or specialized dosage forms
- We receive results; no IND-enabling packages generated internally
Current Partnership
We have partnered with Web3/DeSci projects to get us milestone-based funding per each drug discovery phase.
Partnering Models
- Client pays Immunomodulator a fixed fee to design each molecule/formula.
- Immunomodulator contracts and pays the CRO per discovery phase (in-silico, in-vitro, or in-vivo). A single CRO engagement can cover multiple drug candidates (even across different therapeutic areas) as long as every candidate and every phase is explicitly scoped and billed separately—no blanket retainers, no hidden mark-ups.
- IP ownership: client owns all generated IP (work-for-hire).
Contact Us
We're ready to collaborate. Reach out to the right team to get started.